Test results
| Appearance | Good · Pass |
|---|---|
| Identity | Confirmed · HPLC · Pass |
| Purity | 99.61% · HPLC · Spec ≥ 95.0% · Pass |
| Net peptide content | 1.06 mg · HPLC · Report only |
| Endotoxins | <0.05 EU/mL · LAL · Spec ≤ 5 EU/mL · Pass |
| Fentanyl screen | Not detected · Pass |
Batch details
| Product | IGF1-LR3 |
|---|---|
| Batch / lot | IGF02 |
| Certificate number | COA-2026-SWOMLZ |
| Laboratory | ILS Laboratories (ISO/IEC 17025 accredited) |
| Tested | Jul 31, 2026 |
| Labeled amount | 1mg |
| Method | Purity, Identity & Quantitation (HPLC), Endotoxin (USP <85>) |
| Lab verdict | PASS |
Original certificate
Open the image for the full-size report. Match the lot number printed on your vial to IGF02. Every other batch of IGF1-LR3 is listed on its product page.
New to certificates of analysis? What is a COA? explains the tests on this page and how labs check identity and purity.
Other batches of IGF1-LR3
- Batch 55F, tested May 17, 2026
- Batch #33761, tested Apr 3, 2026
- Batch #29504, tested Nov 11, 2025